Covered recipient · General Payments record
LUCY LEDYARD
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2022–2024
$1,343.61
- Reported across 60 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $389.31 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $170.84 | 16 |
| ABBVIE INC. | $49.27 | 2 |
| GENZYME CORPORATION | $32.21 | 1 |
| Incyte Corporation | $29.21 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.31 | 1 |
| Amgen Inc. | $27.14 | 2 |
| Janssen Biotech, Inc. | $22.50 | 1 |
| E.R. Squibb & Sons, L.L.C. | $17.72 | 1 |
| UCB, Inc. | $13.11 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.24 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104149882 | CMS |
| ABBVIE INC. | $24.03 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104149884 | CMS |
| Amgen Inc. | $13.68 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117307396 | CMS |
| Amgen Inc. | $13.46 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117307398 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.31 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118047398 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.72 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101569148 | CMS |
| GENZYME CORPORATION | $32.21 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139735630 | CMS |
| Incyte Corporation | $29.21 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141283795 | CMS |
| Janssen Biotech, Inc. | $22.50 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078814912 | CMS |
| Lilly USA, LLC | $18.90 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135141577 | CMS |
| Lilly USA, LLC | $10.08 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135139402 | CMS |
| Lilly USA, LLC | $6.14 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135158125 | CMS |
| Lilly USA, LLC | $17.67 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135135104 | CMS |
| Lilly USA, LLC | $6.85 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135149148 | CMS |
| Lilly USA, LLC | $14.43 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135159548 | CMS |
| Lilly USA, LLC | $16.39 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135141579 | CMS |
| Lilly USA, LLC | $0.57 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135135106 | CMS |
| Lilly USA, LLC | $8.57 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135141581 | CMS |
| Lilly USA, LLC | $11.39 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135135108 | CMS |
| Lilly USA, LLC | $7.00 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135097034 | CMS |
| Lilly USA, LLC | $22.03 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135141583 | CMS |
| Lilly USA, LLC | $7.77 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135141585 | CMS |
| Lilly USA, LLC | $11.57 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135097036 | CMS |
| Lilly USA, LLC | $4.32 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135159550 | CMS |
| Lilly USA, LLC | $7.16 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135159940 | CMS |
| UCB, Inc. | $13.11 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143117411 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.